| Issue | Title | |
| Vol 8, No 4 (2015) | HEALTHCARE SPENDING EFFICIENCY IN RUSSIAN REGIONS | Abstract PDF (Rus) |
| N. A. Avxentyev, V. M. Baydin, O. A. Zarubina, N. N. Sisigina, S. A. Kulkova | ||
| Vol 6, No 2 (2013) | HTA CORE MODEL | Abstract |
| R. I. Yagudina, T. Yu. Nor, A. D. Sevostyanov | ||
| Vol 11, No 2 (2018) | Implementation of the Federal Law «On Protection of Consumer Rights» in the provision of paid medical services: recommendations on signing the contract | Abstract PDF (Rus) |
| M. A. Amkhadova, E. V. Batler, D. G. Ilyuhin, I. A. Petrova | ||
| Vol 10, No 4 (2017) | IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET | Abstract PDF (Rus) |
| V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva | ||
| Vol 12, No 1 (2019) | Individual cost accounting in the management of medical organizations | Abstract PDF (Rus) |
| I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali | ||
| Vol 10, No 3 (2017) | Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis | Abstract PDF (Rus) |
| E. V. Biryukova, V. I. Ignat’eva | ||
| Vol 10, No 4 (2017) | INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW | Abstract PDF (Rus) |
| D. G. Tolkacheva, A. V. Torgov, A. S. Margazova | ||
| Vol 10, No 4 (2017) | INTERNATIONAL APPROACHES TO THE GOVERNMENT PRICE CONTROL OVER GENERICS AND BIOSIMILARS: A REVIEW | Abstract PDF (Rus) |
| D. G. Tolkacheva, A. V. Torgov, A. S. Margazova | ||
| Vol 11, No 4 (2018) | International experience in determining the cost-effectiveness thresholds | Abstract PDF (Rus) |
| T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky | ||
| Vol 11, No 2 (2018) | Introduction of medical products into healthcare practice and costs reimbursement: European experience | Abstract PDF (Rus) |
| V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii | ||
| Vol 7, No 4 (2014) | IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? | Abstract PDF (Rus) |
| V. V. Omelyanovskiy | ||
| Vol 8, No 3 (2015) | LEGAL REGULATION OF STATE MANAGEMENT OF MEDICAL SCIENCE | Abstract PDF (Rus) |
| L. S. Melnikova, O. Yu. Rebrova, V. V. Omelyanovskiy | ||
| Vol 8, No 2 (2015) | MAGNESIUM DEFICIENCY OF PATIENTS WITH HORMONE DEPENDENT DISEASES: PHARMACOEPIDEMIOLOGICAL PROFILE AND LIFE QUALITY ASSESSMENT | Abstract PDF (Rus) |
| Dmitry Vladislavovich Blinov, Juliana Vladimirovna Zimovina, Elena Anatol'evna Sandakova, Tat'yana Igorevna Ushakova | ||
| Vol 9, No 2 (2016) | MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE | Abstract PDF (Rus) |
| S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya | ||
| Vol 7, No 2 (2014) | MANAGEMENT OF MAGNESIUM DEFICIENCY IN PREGNANT WOMEN: PHARMACOEPIDEMIOLOGIC STUDY | Abstract PDF (Rus) |
| D. V. Blinov, U. V. Zimovina, E. M. Dzhobava | ||
| Vol 9, No 1 (2016) | MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 | Abstract PDF (Rus) |
| A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum | ||
| Vol 11, No 1 (2018) | Medical care of ambulatory patients and its assessment: a review of international experience | Abstract PDF (Rus) |
| D. V. Lukyantseva, O. A. Sukhorukikh, V. V. Omelyanovsky | ||
| Vol 5, No 2 (2012) | MEDICO-ECONOMIC SUBSTANTIATION OF NORMATIVE STANDARD OF SUPPLYING STUDENTS OF MILITARY SCHOOLS WITH MEDICATIONS | Abstract PDF (Rus) |
| Yu. V. Miroshnichenko, V. S. Gaynov | ||
| Vol 9, No 2 (2016) | METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY | Abstract PDF (Rus) |
| N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov | ||
| Vol 9, No 3 (2016) | METHOD «COST-EFFECTIVENESS» IN EVALUETION OF ATIBIOTIC TREATMENT OF ACYTR OBSTRUCTIVE BRONCHITIS IN CHILDREN IN HOSPITAL | Abstract PDF (Rus) |
| O. V. Zhukova, S. V. Kononova | ||
| Vol 6, No 3 (2013) | METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES | Abstract |
| R. I. Yagudina, A. Ju. Kulikov, D. T. Ugrekhelidze | ||
| Vol 5, No 2 (2012) | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES | Abstract |
| R. I. Yagudina, I. V. Sorokovikov | ||
| Vol 11, No 1 (2018) | Methods of clinical assessment from the “Clinical Recommendations” resource of the Ministry of Healthcare of Russia: a systematic review | Abstract PDF (Rus) |
| V. M. Vatolin, O. A. Sukhorukikh, Zh. A. Galeeva, D. V. Lukyantseva, O. O. Buzuverova, O. V. Kirsanova, E. M. Murtazina, D. G. Ilyukhin, L. S. Shubina | ||
| Vol 7, No 3 (2014) | MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN | Abstract PDF (Rus) |
| V. I. Ignatyeva, M. V. Avxentyeva, V. V. Omelyanovsky, G. R. Khachatryan | ||
| Vol 7, No 4 (2014) | MODELING IN CLINICO-ECONOMIC ANALYSIS OF MEDICAL ORGANIZATIONAL TECHNOLOGIES | Abstract PDF (Rus) |
| M. A. Shapovalova, A. R. Umerova, V. A. Bondarev, L. R. Koretskaya | ||
| Vol 11, No 1 (2018) | Modeling microbial drug-resistance: from mathematics to pharmacoeconomics | Abstract PDF (Rus) |
| Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko | ||
| Vol 11, No 4 (2018) | Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease | Abstract PDF (Rus) |
| V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev | ||
| Vol 5, No 1 (2012) | MODERNIZATION OF THE MEDICAL SERVICES MARKET | Abstract |
| A. U. Kulikov | ||
| Vol 9, No 3 (2016) | MONITORING OF CONSUMER ATTITUDES TO MEDICINES | Abstract PDF (Rus) |
| N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka | ||
| Vol 12, No 2 (2019) | New framework for the development of clinical guidelines in Russia | Abstract PDF (Rus) Приложение (Rus) |
| D. V. Blinov, E. S. Akarachkova, A. S. Orlova, E. V. Kryukov, D. I. Korabelnikov | ||
| Vol 8, No 3 (2015) | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL | Abstract PDF (Rus) |
| D. V. Blinov | ||
| Vol 11, No 3 (2018) | Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review | Abstract PDF (Rus) |
| D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin | ||
| Vol 12, No 4 (2019) | Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation | Abstract PDF (Rus) |
| A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev | ||
| Vol 11, No 1 (2018) | Options to optimize the access to biosimilars: analysis and solutions | Abstract PDF (Rus) |
| O. V. Kirsanova, V. V. Omelyanovsky | ||
| Vol 8, No 3 (2015) | ORGANIZATION AND ANALYSIS OF THE COMMISSION'S WORK ON THE SELECTION AND REFERRAL OF PATIENTS IN A MEDICAL INSTITUTION FOR TREATMENT USING ASSISTED REPRODUCTIVE TECHNOLOGIES ON THE TERRITORY OF THE CHELYABINSK REGION | Abstract PDF (Rus) |
| M. G. Moskvicheva, V. V. Saharova, Yu. A. Semenov, E. V. Orehova | ||
| Vol 11, No 4 (2018) | Organization and financial support of healthcare for public employees in the Russian Federation: a review of departmental health services in the Ministry of Defense | Abstract PDF (Rus) |
| D. V. Lukyantseva, L. S. Melnikova, D. V. Fedyaev, T. P. Bezdenezhnykh, V. V. Omelyanovskiy | ||
| Vol 12, No 2 (2019) | Organizational structure and funding of health technology assessment agencies around the world | Abstract PDF (Rus) |
| G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak | ||
| Vol 12, No 3 (2019) | Overview of the existing opportunities and limitations of the state guarantees program for provision of free medical care to citizens | Abstract PDF (Rus) |
| D. V. Fedyaev , R. V. Gostishchev , V. A. Lemeshko , O. I. Ivakhnenko | ||
| Vol 7, No 2 (2014) | PARAMETERS OF HEALTH CARE SYSTEMS | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, I. V. Maksimova, A. P. Tatarinov | ||
| Vol 11, No 4 (2018) | Patient registers and account registries of compulsory medical insurance: integration and replaceability | Abstract PDF (Rus) |
| I. A. Zheleznyakova, G. I. Pirova, E. A. Proxorovich | ||
| Vol 7, No 1 (2014) | PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY | Abstract PDF (Rus) |
| D. V. Blinov | ||
| Vol 8, No 1 (2015) | PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION | Abstract PDF (Rus) |
| L. S. Melnikova | ||
| Vol 10, No 1 (2017) | PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM | Abstract PDF (Rus) |
| N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova | ||
| Vol 5, No 1 (2012) | PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION | Abstract |
| R. Yagudina, A. Kulikov, B. Misikova | ||
| Vol 6, No 4 (2013) | Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia | Abstract |
| R. I. Yagudina, I. Yu. Zinchuk | ||
| Vol 6, No 4 (2013) | Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment | Abstract |
| A. U. Kulikov, V. V. Babiy | ||
| Vol 10, No 1 (2017) | PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS | Abstract PDF (Rus) |
| A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina | ||
| Vol 12, No 2 (2019) | Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria | Abstract PDF (Rus) |
| S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova | ||
| Vol 9, No 2 (2016) | PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION | Abstract PDF (Rus) |
| T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva | ||
| Vol 6, No 3 (2013) | PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER | Abstract |
| R. I. Yagudina, I. Yu. Zinchuk | ||
| 101 - 150 of 266 Items | << < 1 2 3 4 5 6 > >> | |
Browse Title Index
Keywords
ABC analysis
NAFLD
Pharmacoeconomics
QALY
biosimilar
budget impact analysis
chemotherapy
children
clinical and economic analysis
cost-effectiveness analysis
cost-utility analysis
direct costs
drug supply
health technology assessment
pharmacoeconomic analysis
pharmacoeconomic modeling
pharmacoeconomic studies
pharmacoeconomics
pharmacoepidemiology
rare diseases
systematic review
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
